Source: International Congress 2014 – Comorbidities in sleep disordered breathing - clinical consequences and therapeutic solution



Rating:

Share or cite this content

Citations should be made in the following way:
J. Ficker (Herzogenaurach, Germany). Introduction: current data "Comorbidities in SDB". International Congress 2014 – Comorbidities in sleep disordered breathing - clinical consequences and therapeutic solution

Member's Comments

No comment yet.

Related content which might interest you: Introduction “Never say no: current trends in asthma phenotyping” Source: Annual Congress 2009 - One size (does not) fit all: phenotyping and controlling asthma Year: 2009 Introduction "Introductory lecture on complex sleep apnoea" Source: Annual Congress 2009 - Complex sleep apnoea and adaptive servo ventilation Year: 2009 Introduction to COPD: terminology and aetiology Source: Annual Congress 2006 - PG13 - COPD: from aetiology to management Year: 2006 Treatment of OSA in obese children: a "big" issue Source: Annual Congress 2012 - Treatment of paediatric sleep-disordered breathing in special populations Year: 2012 COPD: Introduction from the chairs Source: ERS Satellites 2021 Year: 2021 Introduction: Implementation of evidence-based care: how to put science into practice Source: Annual Congress 2003 - Implementation of evidence-based care in Allied Respiratory Professionals Year: 2003 Definition of COPD: based on evidence or opinion? Source: Eur Respir J 2008; 31: 681-682 Year: 2008 "Trial-skilled" patients: How big the improvement in cooperation? Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases Year: 2013 Introduction: why CPET? Source: ERS Course 2017 Year: 2017 Introduction: SDB digital health technologies Source: 5th Sleep and Breathing Conference Year: 2019 2-Conclusion "Paediatric aspects of SIT and other PRO/CON in childhood asthma" Source: Annual Congress 2010 - Pro/Con debates: 1. To screen or not to screen for cystic fibrosis: is it still the question, 2. Specific immunotherapy for asthma Year: 2010 Pro/Con Debate "Maintenance of exercise capacity following pulmonary rehabilitation in COPD: is there any relationship with inflammation and nutritional status?" - PRO Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD Year: 2011 Can " Beta-blockers" be useful to treat asthma? Source: Annual Congress 2009 - Beta-blockers may now be beneficial in asthma and COPD Year: 2009 LATE-BREAKING ABSTRACT: The infrequent "frequent" exacerbator: An analysis of the SPIROMICS cohort Source: International Congress 2016 – From pleura to bronchi: new insights Year: 2016 Association of patient-perceived COPD symptoms & activity limitations with comorbidities: The "COPD language" study Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013 COPD: Still a Cinderella? Source: Eur Respir J 2003; 22: Suppl. 45, 67s Year: 2003 Pro/Con Debate "Muscle dysfunction, systemic inflammation and rehabilitation: is physical activity beneficial in COPD?" - PRO Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD Year: 2011